Healthcare · Vaccine antigens production

Vaccine antigens production in Germany in 2026

In 2026, Germany produced 30 million doses vaccine antigens, ranking 9 out of 197. The zero figure reflects the country's focus on developing and manufacturing vaccine components, such as mRNA technology, rather than final doses. German BioNTech became a global leader in COVID-19 vaccines, but statistics count only finished doses, not active substances.

Data for 2026 · unit: million doses
Position

Germany world ranking

#9 / 197

Country position on the scale from last to first place for this indicator.

DE
#9
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
50
1990
100
2000
200
2010
300
2020
30
2025
30
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Germany — how much?
Based on 2026 data — 30 million doses. This is rank #9 out of 197 countries.
What is Germany's rank by Vaccine antigens production?
Germany ranks #9 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Germany?
Over the available period the indicator changed from 1 to 30 million doses.